SimonMed Integrates FDA-Approved InferRead Lung CT.AI by Infervision at Facilities

SCOTTSDALE, Ariz., April 12, 2024 – SimonMed Imaging (“SimonMed”), one of many largest outpatient medical imaging suppliers and radiology practices within the United States, introduced as we speak the combination of Infervision’s FDA-approved AI-powered InferRead Lung CT.AI know-how at SimonMed amenities. This cutting-edge know-how goals to boost the identification of pulmonary nodules in sufferers, with considerably elevated nodule detection, in addition to 3-D characterization and comparability of nodules. It will probably be built-in into CT chest scan readings, together with these for lung most cancers screening.

Dr. John Simon, CEO and Founder, commented “The utilization of Infervision Lung CT.AI is one other instance of SimonMed utilizing the most recent technological developments to enhance affected person care by serving to to supply extra correct diagnoses together with utilizing multi-dimensional analyses to raised establish sequential modifications in nodules, in addition to offering improved detection sensitivity. In addition, the know-how can establish and assist create prioritization of acute instances resembling pneumonia.”

Matt Deng, Vice president, and Head of Infervision America, commented “At Infervision, our mission is to enhance human life with AI. This collaboration highlights AI’s superior capabilities in detecting and characterizing pulmonary nodules and demonstrates our dedication to enhancing affected person care. We are proud to accomplice with SimonMed Imaging to carry this cutting-edge know-how to healthcare suppliers and sufferers, driving the way forward for healthcare by means of AI innovation.”

The know-how routinely shows containers round nodules in a brand new collection offering standardized reporting of all nodule traits together with picture quantity, kind of nodule, and quantity. Additionally, it assesses earlier exams to trace modifications in diameter and quantity. In instances the place pneumonia is suspected, the know-how prioritizes them for instant reporting.

InferRead Lung CT.AI is engineered to help radiologists in pulmonary nodule detection throughout the overview of chest CT scans, rising accuracy and effectivity. The collaboration is one among many AI tasks underway at SimonMed to proceed to advance the affected person expertise by means of new applied sciences.